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A series of data has accumulated over the past five years that raises questions about our current understanding
of the transcriptional process and its regulation. Following the discovery of coactivators for nuclear receptors
(NRs), a large number of these molecules have been reported in the literature.This perspective will summarize
some opinions on the significance of this large number of factors.
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Sequentiality and Processivity of
Nuclear Receptor Coregulators
A series of data has accumulated over the past five years
that raises questions about our current understanding of
the transcriptional process and its regulation. Following
the discovery of coactivators for nuclear receptors (NRs),
we have been amazed at the plethora of these molecules
that have been reported in the literature [] McKenna et
al., 1999 ; [ McKenna and O'Malley, 2002 ]. A cursory
inspection, not attempting to critique and eliminate those
that may not be true coactivators, sets the number at over
100.The impressive size of this number begs an
explanation – and the explanation appears to reside in
the many diverse cellular roles for coactivators.
The large number of coactivators is explained in part by
the fact that our concept of coactivator function has
expanded considerably. As we might have guessed, there
is receptor selectivity for coactivators [ Li et al., 2003 ],
although how many of the 48 human nuclear receptors
use distinct or unique coactivators is unknown at present.
Evidence for ligand-specific recruitment of coactivators
is in the literature [ Korzus et al., 1998 ], and
promoter-gene specific requirements for coactivators
probably occur in certain instances [ Puigserver et al.,
1998 ]. Interestingly, there is evidence for cell specific
expression for only a limited number of coactivators .
Data are accumulating rapidly that suggest that
coactivators play major roles in many diverse cellular
processes such as the coordination of expression of gene
sets that regulate metabolic processes [ Picard et al.,
2002 ; Puigserver et al., 1998 ].These molecules have
the capacity to bind to functional sets of DNA-bound
transcription factors and coordinately enhance the
expression of groups of genes required for certain
metabolic functions. Coactivators are known to play a
role in regulating cell growth, and consequently are often
overexpressed in cancers [ Anzick et al., 1997 ].
Coactivators also act as intracellular targets for signaling
from membrane receptors [ Wu et al., 2002 ], providing
homeostatic sensing to the internal NR pathways from
membrane receptor regulated pathways.
In terms of transcriptional regulation, we initially
considered coactivators as simply ‘power boosters′ for
DNA-binding transcription factors such as NRs, capable
of accelerating the process of transcription initiation.We
now understand that coactivators are involved in more
diverse steps of transcription than only the step of
‘initiation′ of transcription.This new information leads us
to reconsider some of our ideas on hormonal regulation
of the transcription process.
There are a few newly available pieces of data that must
be taken into account in any theory of NR mediated gene
activation. Firstly, it recently has been shown that
coactivators (in addition to NRs themselves) have a very
short residence time at promoter sites during real time
imaging of the nucleus [ McNally et al., 2000 ; Stenoien
et al., 2001 ]. Secondly, in steady state conditions in cells,
coactivators exist in high molecular weight complexes
(~4-6 proteins), and thus are unlikely to enter the
regulatory complex one by one [ McKenna et al., 1998 ].
Our data indicates that these high molecular weight
complexes are very heterogeneous and contain many
combinations of different coactivators.Thirdly, it is likely
that in most instances, a member of the SRC-1 family
forms the initial primary bond with steroid receptors to
initiate transcription. Fourthly, NR coactivators play a role
in alternative RNA splicing [ Auboeuf et al., 2002 ;
Monsalve et al., 2000 ] and in termination of regulated
transcription [ Lonard et al., 2000 ; Nawaz et al., 1999 ],
and perhaps other subreactions of the transcriptional
process. Fifthly, most of the published coactivators
interact directly with NRs and do so at only two major
sites, the AF-2 region in the ligand binding domain and
the AF-1 region in the N-terminus.
Most certainly, coactivator binding to receptor AFs is
governed by a combination of the intracellular
concentration of each of the coactivators and their
individual affinities for a given receptor AF.The product
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receptor binding site.Thus, many coactivators may not
come into play at a given receptor, when occupied by a
given ligand at a given promoter. Biochemical reactions
in a cell are in equilibrium and are thereby open to shifts
in this equilibrium. For example, a cell may increase its
concentration of a specific coactivator under certain
conditions. An example is the demonstration that fasting
increases the concentration, and thus function, of PGC-1
in the liver.This is not the norm for coactivators, however,
since most do not change dramatically in concentration
during the lifetime of a normal differentiated cell. Perhaps
more commonly, post-translational modifications of
coactivators increase or reduce the affinities of a
coactivator for a given set of transcription factors.
Post-translational modifications of coactivators, such as
phosphorylation or acetylation/methylation have been
reported to increase or decrease the affinity of the
modified coactivator for target receptors or other
coactivators [ Dutertre and Smith, 2003 ; Rowan et al.,
2000 ].
Nevertheless, despite the above explanations which could
account for a significant proportion of coactivators, the
extensive number of reported coactivators that stimulate
NR mediated transcription is still very large, and the fact
remains that the vast majority of these coactivators bind
at the same AF-1 and AF-2 sites of receptors.These two
facts force us to ‘think out of the box′ in terms of their
function.
Thus, we and others have searched for additional novel
functions not easily predicted for coactivators at the time
of their discovery. Early on, coactivators were discovered
that appear to dictate ubiquitinylation of the coactivator
complex and were predicted to play a role in short-term
or long-term turnover of the active complex by the 26S
proteasome [ Lonard et al., 2000 ; Nawaz et al., 1999 ].
A subset of coactivators has been implicated in the
regulation of alternative mRNA processing;
receptor-coactivator regulation of RNA splicing occurs
coordinately with transcriptional regulation [ Auboeuf et
al., 2002 ]. Perhaps future studies even will extend their
functions to the other intermediate reactions of RNA chain
elongation, RNA 5′ - and 3′ - processing, and transport
of mRNA to the cytoplasmic ribosomes.These
considerations might account for the presence of many
more coactivators in cells, but only if they do not act
simultaneously, because they all must enter AF-2 and
AF-1 regions to perform their functions.
Consequently, an argument can be made for sequential
kinetics for coactivator-complex entry to AF-1/AF-2 sites.
This explanation is not as radical as it sounds, since it
already has been suggested as an explanation to resolve
the conflict as to whether SRC/p160 family members are
the important coactivators for NRs such as TR and VDR,
or whether the SMCC-type (TRAPs/DRIPs) complex of
coactivators (TRAPs/DRIPs) represent the functional
complex [ Oda et al., 2003 ; Sharma and Fondell, 2002
]. If they act in sequence, then both are necessary but
not sufficient.
Once we turn to kinetics for an explanation of the
AF-dependent interaction, why not take the hypothesis
one step further- and predict sequential interactions for
multiple additional coactivator complexes in each target
gene activation. It is now only one additional leap of faith
to suggest that there also may be many additional
nonproductive interactions for coactivator complexes that
currently are beyond our ability to monitor with
time-dependent ChIP analyses, or to prove even with
technologies such as real- time live imaging. It might be
remembered that gene expression may not be effected
by the ′exact′ series of reactions that are indicated in our
diagrams of the process. RNA polymerase II makes many
false starts and forms multiple short incomplete RNA
chains in the course of gene transcription. In other words,
each RNA start by the enzyme is not necessarily
productive.
In Figure 1 , we speculate that a sequence of stochastic
nonproductive interactions of diverse coactivator
complexes leads to an eventual productive interaction
with a steroid receptor dimer in place at the promoter of
a gene.The exact complexes and sequence are less
important than the concept.When a specific and
productive interaction occurs, transcription advances one
functional step forward; the receptor next must seduce a
new productive interaction with a different requisite
coactivator complex that advances the gene through the
next subreaction needed for effective transcription. Each
individual step in this process is likely replete with
additional nonproductive interactions, but since the
half-life of coactivator interactions at promoters has been
estimated to be less than 20 seconds, little time is lost in
discharging an inappropriate complex and recruiting the
next correct coactivator complex required to produce a
translatable mRNA.
Figure 1 . Model for sequential interactions of diverse coactivator
complexes with a steroid receptor dimer at the promoter of a gene.
See text for more details.
Such a sequence of events is not illogical. In fact, it may
be illogical to propose a precise vectoral movement of
coactivator complexes directly to their sites of action.
There is no doubt that subcellular targeting is possible
using peptides and other types of signals, but it is difficult
to accept this as an explanation for the myriad individual
gene activities in the eukaryotic nucleus, especially in the
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concentrations of coactivators. How the correct
receptor-coactivator complex for a substep of transcription
might signal its validity when it enters the promoter is
unknown. Suspicion centers on the many recently
discovered posttranslational modifications capable for
proteins on the chromosome, including phosphorylation,
methylation, acetylation, ubiquitinylation/sumoylation and
glycosylation [ McKenna and O'Malley, 2002 ].
When finally defined, the series of steps in decoding a
gene is likely not to be as linear and precise as we once
thought.The rapid kinetics inherent to simple diffusion
and concentration may lie at the heart of the process. In
any event, as usual in biology, it will appear beautiful in
its evolutional simplicity when unraveled.
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